Eli Lilly and Company

PORTRAZZA

Manufacturer:

Eli Lilly and Company

Portrazza HCPCS:

J9295

HCPCS Code Descriptor:

Injection, necitumumab, 1 mg

Category:

J Code

Portrazza NDCs:

00002-7716-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Portrazza:

PORTRAZZA is an Oncology drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The J Code: J9295 is aligned to the drug PORTRAZZA.

ACCESS PRICING AND MORE BY REGISTERING

J9295 Added Date:

January 1, 2017

J9295 Effective Date:

January 1, 2017

J9295 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Portrazza billing and coding information.
Portrazza patient assistance information can be found through the Lilly Cares Foundation at the URL: http://www.lillycares.com
PORTRAZZA prescribing information can be found at the link below:
Information regarding PORTRAZZA’s side effects can be found at MedlinePlus